Bibliography
- RABE KF, TIMMER W, SAGRIOTIS A, VIEL K: Comparison of a combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPD. Eur. Respir. J. (2005) 26 (Suppl. 49):14s.
- VAN NOORD JA, AUMANN J-L, JANSSENS E et al.: Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur. Respir. J. (2005) 26:214-222.
- CAZZOLA M, SANDUZZI A, VATRELLA A, CALIFANO C, PONTICIELLO A, SALZILLO A: The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD. Eur. Respir. J. (2005) 26(Suppl. 49):577s.
- DI MARCO F: Formoterol (Modulite), tiotropium and their combination in patients with acute exacerbation of chronic bronchitis: preliminary data. Eur. Respir. J. (2005) 26(Suppl. 49):285s.
- RAZZETTI R, CIVELLI M, BERTI F, ROSSONI G: Carmoterol, a new long-acting β2-agonist, positively interacts with M3-muscarinic antagonist. Eur. Respir. J. (2005) 26(Suppl. 49):215s.
- RAZZETTI R, PASTORE F, CIVELLI M, ROSSONI G: Positive interaction of carmoterol, a new long-acting β2-agonist, with budesonide. Eur. Respir. J. (2005) 26(Suppl. 49):215s.
- PAHL A, MAUS J, CNOTA P, PETZOLD U, SZELENYI I: Synergistic action of the anticholinergic r,r-glycopyrrolate with glucocorticoids and PDE4-inhibitors. Eur. Respir. J. (2005) 26(Suppl. 49):217s.
- ELLIOT JG, CARROLL NG, JAMES AL, ROBINSON PJ : Airway alveolar attachment points and exposure to cigarette smoke in utero. Am. J. Resp. Crit. Care Med. (2003) 167:45-49.
- SMITH AD, COWAN JO, BRASSETT KP, HERBISON GP, TAYLOR DR: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. (2005) 352:2163-2173.
- BRANNAN JD, CAILLAUD C, ANDERSON SD: Montelukast sodium (MS) in addition to sodium cromoglycate (SCG) on the airway response to the same cumulative dose of inhaled mannitol. Eur. Respir. J. (2005) 26(Suppl. 49):370s.
- BRANNAN JD, FREED-MARTENS R, ANDERSON SD, AND THE ARIDOL STUDY GROUP: Effect of treatment on recovery to mannitol challenge: a Phase III study. Eur. Respir. J. (2005) 26(Suppl. 49):371s.
- LEUPPI JD, SALOME CM, JENKINS CR et al.: Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am. J. Resp. Crit. Care. Med. (2005) 171:1065-1066.